findmyKOL
Clinical trialNCT03919162TerminatedPhase 2Interventional

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

SponsorVivoryon Therapeutics N.V.Enrollment112Alzheimer Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

  • Banner Sun Health Research Institute

    Sun City, Arizona, United States

  • the Neuron Clinic

    Chula Vista, California, United States

  • University of California

    Irvine, California, United States

  • Ucsd Alzheimer'S Disease Research Center

    La Jolla, California, United States

  • Cedars-Sinai Center

    Los Angeles, California, United States

  • Pcnd Neurology

    Poway, California, United States

  • Georgetown University Medical Center

    Washington D.C., District of Columbia, United States

  • Usf Health Byrd Alzheimer'S Center and Research Institute

    Tampa, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, United States

  • the University of Iowa Carver College of Medicine

    Iowa City, Iowa, United States

  • the University of Kentucky Sanders-Brown Center on Aging

    Lexington, Kentucky, United States

  • Northern Light Acadia Hospital

    Bangor, Maine, United States

  • Nyu Langone Health Tisch Hospital

    New York, New York, United States

  • Suny Upstate Medical University

    Syracuse, New York, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Ohsu Neurology Clinic

    Portland, Oregon, United States

  • Abington Neurological Associates

    Abington, Pennsylvania, United States

  • Rhode Island Hospital

    Providence, Rhode Island, United States

  • Lowcountry Center for Veterans Research (lcvr)

    Charleston, South Carolina, United States

  • Ut Health San Antonio

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Nov 2021
Primary completion
12 Jul 2024
Completion
12 Aug 2024
Last update posted
12 Dec 2025
Registered enrollment
112
Registry id
NCT03919162

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.